Week in Review: December 7–11

Effects of experimental brain manipulations questioned; long-lived memory T cells; more GM microbe “kill switches”; CRISPR therapy in a dish

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WIKIMEDIA, PERIPITUSIn rats and zebra finches, transient brain manipulations show different functional effects than permanent lesions in the same regions, a team led by investigators at Harvard reported this week (December 9) in Nature. Further, the researchers showed that both transient inactivation and stimulation of a particular region in the rat brain impaired the animal’s performance on a given task, hinting at acute widespread circuit dysfunction that could confuse research results.

“This is a paper that had to be done,” said Giulio Tononi of the University of Wisconsin who was not involved in the study. “The work is very elegant, very careful, and it shows something that one could definitely suspect . . . but that has never been shown so explicitly.”

FLICKR, NIAIDSynthetic gene circuits called “kill switches” ensure that genetically modified (GM) bacteria survive only under certain environmental conditions. This week (December 7) in Nature Chemical Biology, an MIT-led team described two such circuits, which could be used to rein in engineered microbes designed for environmental remediation efforts, among other things.

“This is yet another step forward towards better biosafety and biocontainment based on certain aspects of existing technology,” said Guy-Bart Stan of Imperial College London who was not involved in the study. “Using some existing genetic circuitry . . . you can obtain biosafety for the here and now.”

WIKIMEDIA, NCIScientists in Milan have identified two types of memory T cells that stand the test of time. The team sampled the blood of patients who had received hematopoietic stem cell transplants spiked with genetically marked donor memory T cells and showed that two types of memory T cells can persist in people for up to 14 years. The results were published this week (December 9) in Science Translational Medicine.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Tracy Vence

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours